{"id":817549,"date":"2025-02-25T08:35:59","date_gmt":"2025-02-25T13:35:59","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/"},"modified":"2025-02-25T08:35:59","modified_gmt":"2025-02-25T13:35:59","slug":"robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/","title":{"rendered":"Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting"},"content":{"rendered":"<h2>\nResearch Collaboration demonstrates the feasibility of using the LIBERTY\u00ae Endovascular Robotic System between separate and remote facilities in a coronary simulation model<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"justify\">BRAINTREE, Mass., Feb.  25, 2025  (GLOBE NEWSWIRE) &#8212;  Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY<sup>\u00ae<\/sup> Endovascular Robotic System, today announced its collaboration with Corewell Health\u2122\u00a0has reached another meaningful milestone. Under a collaboration agreement, Microbot Medical<sup>\u00ae<\/sup> and Corewell Health\u2122\u00a0are working together to advance robotic telesurgery for endovascular applications. Led by Ryan Madder, M.D., Section Chief of Interventional Cardiology and Director of the Cardiac Cath Lab at Corewell Health\u2122 in Grand Rapids, Michigan, the project assesses the feasibility of using LIBERTY<sup>\u00ae<\/sup> to perform simulated cardiovascular interventional procedures across two sites within the Corewell Health\u2122 system located 5 miles apart. The research has been accepted for presentation at the Cardiovascular Research Technologies (CRT) annual meeting, being held from March 8-11, 2025, in Washington D.C., and will be published in the Journal of the American College of Cardiology (JACC) Interventions online edition.\u00a0\u00a0<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Abstract\/Presentation Title<\/strong>: Feasibility of Telerobotic Coronary Artery Wiring Using A Novel Miniaturized Robotic System: A Pre-clinical Ex Vivo Study<\/li>\n<li style=\"text-align:justify\">\n          <strong>Presenter:<\/strong> Trisha Gomez, MD<\/li>\n<li style=\"text-align:justify\">\n          <strong>Presentation Date\/Time<\/strong>: Monday, March 10, 2025, 4:12-4:20pm ET.<\/li>\n<li style=\"text-align:justify\">\n          <strong>Location:<\/strong> Theater #4<\/li>\n<\/ul>\n<p align=\"justify\">\u201cIn this study, the LIBERTY<sup>\u00ae<\/sup> robotic system functioned well in a telerobotic setting. The system\u2019s small footprint and disposable design create a multitude of exciting possibilities for future telerobotic endovascular procedures,\u201d commented Dr. Madder.<\/p>\n<p>\u201cWe\u2019re excited that this groundbreaking research, led by Dr. Madder and the Corewell Health team, has been selected for presentation, which we believe reflects the importance of integrating telesurgery in the future of healthcare,\u201d commented Harel Gadot, Chairman, CEO and President. \u201cIncorporating telesurgery capabilities is an important part of our long-term strategy for LIBERTY<sup>\u00ae<\/sup>, and we are pleased to demonstrate its feasibility. We believe that robotic telesurgery will increase access to high quality healthcare for patients in remote locations in the US and around the world.\u201d<\/p>\n<p align=\"justify\">Cardiovascular Research Technologies (CRT) is a leading educational forum on new cardiovascular technology and procedures for physicians and health-care professionals. CRT provides a forum for exemplary education for interventional cardiologists, general cardiologists, cardiothoracic and vascular surgeons, catheterization laboratory managers, nurses and technologists, scientists and those with an interest in cardiovascular medicine.<\/p>\n<p align=\"justify\">The telesurgery feature of LIBERTY<sup>\u00ae<\/sup> is still under development at Microbot and is not covered under its pending 510(k) premarket submission with the U.S. Food and Drug Administration.<\/p>\n<p align=\"justify\">\n        <strong>About Microbot Medical<\/strong><br \/>\n        <sup>\u00ae<\/sup><br \/>\n        <br \/>Microbot Medical Inc. (NASDAQ: MBOT) is a pre-commercial stage medical technology company with a vision to improve the quality of care for millions of patients and providers globally. The Company has developed the world\u2019s first single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems.<\/p>\n<p>Further information about Microbot Medical<sup>\u00ae<\/sup> is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=P30u4TAvn5dEKX4BvgTDmNEMPhznuWf4YsKRjyi9984ldqIzJcu4qwvKMGd0Mu4DoOmBifXNvUvTLp1T7zclKWCPQ9B1zV6tRUlpxBObieD4wXxh_SgGj0Z4TFa5Gg2q\" rel=\"nofollow\" target=\"_blank\">http:\/\/www.microbotmedical.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Safe Harbor<\/strong><br \/>\n        <br \/>Statements to future financial and\/or operating results, future growth in research, technology, clinical development, commercialization and potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that contain words such as \u201cwill,\u201d \u201cbelieves,\u201d \u201cplans,\u201d \u201canticipates,\u201d \u201cexpects\u201d and \u201cestimates\u201d) should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, the Company\u2019s need for and ability to obtain additional working capital to continue its transition to a commercially focused company, market conditions, risks inherent in the development and\/or commercialization of the LIBERTY<sup>\u00ae<\/sup> Endovascular Robotic System, including its potential telesurgery feature, uncertainty in the results of regulatory pathways and regulatory approvals, including whether the FDA will grant 510(k) clearance to commercially market the LIBERTY<sup>\u00ae<\/sup> Endovascular Robotic System in the United States, disruptions resulting from new and ongoing hostilities between Israel and the Palestinians and other neighboring countries, and maintenance of intellectual property rights. Additional information on risks facing Microbot Medical<sup>\u00ae<\/sup> can be found under the heading \u201cRisk Factors\u201d in Microbot Medical\u2019s periodic reports filed with the Securities and Exchange Commission (SEC), which are available on the SEC\u2019s web site at www.sec.gov. Microbot Medical<sup>\u00ae<\/sup> disclaims any intent or obligation to update these forward-looking statements, except as required by law.<\/p>\n<p>\n        <strong>Investor Contact: <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JgbnmEwDudrcLNBuFlQDMEZBAICKKiz2Jdysp1-fbszozC1kmPgXdlGiRrWRADM2QzHFdm9htCTH5WlZCbt8u-IB-mcMC9TkT9D_95hnqCk=\" rel=\"nofollow\" target=\"_blank\">IR@microbotmedical.com<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk0OCM2Nzc2NjE1IzIwODI0OTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OWNhMDg0MjgtYjM4Zi00YjZlLWEyOTQtNzY4ZGQwOThlNDA5LTEwOTQwNjg=\/tiny\/Microbot-Medical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Research Collaboration demonstrates the feasibility of using the LIBERTY\u00ae Endovascular Robotic System between separate and remote facilities in a coronary simulation model BRAINTREE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY\u00ae Endovascular Robotic System, today announced its collaboration with Corewell Health\u2122\u00a0has reached another meaningful milestone. Under a collaboration agreement, Microbot Medical\u00ae and Corewell Health\u2122\u00a0are working together to advance robotic telesurgery for endovascular applications. Led by Ryan Madder, M.D., Section Chief of Interventional Cardiology and Director of the Cardiac Cath Lab at Corewell Health\u2122 in Grand Rapids, Michigan, the project assesses the feasibility of using LIBERTY\u00ae to perform simulated cardiovascular interventional procedures across two sites within the Corewell Health\u2122 system located 5 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-817549","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Research Collaboration demonstrates the feasibility of using the LIBERTY\u00ae Endovascular Robotic System between separate and remote facilities in a coronary simulation model BRAINTREE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY\u00ae Endovascular Robotic System, today announced its collaboration with Corewell Health\u2122\u00a0has reached another meaningful milestone. Under a collaboration agreement, Microbot Medical\u00ae and Corewell Health\u2122\u00a0are working together to advance robotic telesurgery for endovascular applications. Led by Ryan Madder, M.D., Section Chief of Interventional Cardiology and Director of the Cardiac Cath Lab at Corewell Health\u2122 in Grand Rapids, Michigan, the project assesses the feasibility of using LIBERTY\u00ae to perform simulated cardiovascular interventional procedures across two sites within the Corewell Health\u2122 system located 5 &hellip; Continue reading &quot;Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-25T13:35:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk0OCM2Nzc2NjE1IzIwODI0OTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting\",\"datePublished\":\"2025-02-25T13:35:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\\\/\"},\"wordCount\":748,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzk0OCM2Nzc2NjE1IzIwODI0OTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\\\/\",\"name\":\"Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzk0OCM2Nzc2NjE1IzIwODI0OTc=\",\"datePublished\":\"2025-02-25T13:35:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzk0OCM2Nzc2NjE1IzIwODI0OTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzk0OCM2Nzc2NjE1IzIwODI0OTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting - Market Newsdesk","og_description":"Research Collaboration demonstrates the feasibility of using the LIBERTY\u00ae Endovascular Robotic System between separate and remote facilities in a coronary simulation model BRAINTREE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY\u00ae Endovascular Robotic System, today announced its collaboration with Corewell Health\u2122\u00a0has reached another meaningful milestone. Under a collaboration agreement, Microbot Medical\u00ae and Corewell Health\u2122\u00a0are working together to advance robotic telesurgery for endovascular applications. Led by Ryan Madder, M.D., Section Chief of Interventional Cardiology and Director of the Cardiac Cath Lab at Corewell Health\u2122 in Grand Rapids, Michigan, the project assesses the feasibility of using LIBERTY\u00ae to perform simulated cardiovascular interventional procedures across two sites within the Corewell Health\u2122 system located 5 &hellip; Continue reading \"Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-25T13:35:59+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk0OCM2Nzc2NjE1IzIwODI0OTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting","datePublished":"2025-02-25T13:35:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/"},"wordCount":748,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk0OCM2Nzc2NjE1IzIwODI0OTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/","name":"Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk0OCM2Nzc2NjE1IzIwODI0OTc=","datePublished":"2025-02-25T13:35:59+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk0OCM2Nzc2NjE1IzIwODI0OTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk0OCM2Nzc2NjE1IzIwODI0OTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/robotic-telesurgery-data-from-collaboration-with-corewell-health-accepted-for-presentation-at-the-cardiovascular-research-technologies-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Robotic Telesurgery Data from Collaboration with Corewell Health\u2122 Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/817549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=817549"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/817549\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=817549"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=817549"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=817549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}